These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8147692)

  • 1. What patient with essential hypertension should receive antihypertension drug therapy?
    Chasis H
    Arch Intern Med; 1994 Apr; 154(7):824. PubMed ID: 8147692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive drug therapy in relation to lipid disorders].
    Kawecka-Jaszcz K; Stochmal A
    Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When and why to start drug therapy in essential hypertension].
    Oliva G; Fallani P; Mete A; Covello R; Avallone A
    Clin Ter; 1987 Oct; 123(1):51-5. PubMed ID: 2972467
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.
    Bisognano JD; Horwitz LD
    West J Med; 1998 Apr; 168(4):272-4. PubMed ID: 9584674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Revised hypertension guidelines].
    Aumiller J
    MMW Fortschr Med; 2008 Jul; 150(28-31):62-3. PubMed ID: 19006893
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension in the elderly: a patient case study.
    Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():22A-24A. PubMed ID: 10205253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of essential hypertension with Saltubol].
    Hirsch W; Gaumitz E
    Ther Ggw; 1969 Jun; 108(6):859-60 passim. PubMed ID: 5383167
    [No Abstract]   [Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
    Waeber B; Vetter W; Darioli R; Keller U; Brunner HR
    Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evaluation of hypertensive patients' adherence to the pharmacological treatment of hypertension].
    Tomaszewski M; Lacka B; Zukowska-Szczechowska E; Grzeszczak W; Gosek K
    Wiad Lek; 1999; 52(11-12):573-80. PubMed ID: 10745694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the therapy of essential hypertension].
    Sturm A
    Med Welt; 1968 Apr; 14():849-56. PubMed ID: 5718190
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive drug therapy in Saskatchewan.
    Hollenberg NK
    Curr Hypertens Rep; 2002 Jun; 4(3):179. PubMed ID: 12058694
    [No Abstract]   [Full Text] [Related]  

  • 13. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' experiences of antihypertensive drugs in routine use: results of a Danish general practice survey.
    Borrild NJ
    Blood Press Suppl; 1997; 1():23-5. PubMed ID: 9285104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A critical consideration of drug therapy in arterial hypertension].
    Scheler F; Valentin R
    Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():219-23. PubMed ID: 6666305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Do we need a new strategy in hypertension treatment?].
    Beaufils M
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):630-5. PubMed ID: 12555469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertension: a new treatment combined with acetylsalicylic acid].
    Vervaeren J
    J Pharm Belg; 1998; 53(5):309-14. PubMed ID: 9835674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications for antihypertensive drug therapy. German League for the Control of Hypertension].
    Fortschr Med; 1990 Aug; 108(25):485-7. PubMed ID: 2210586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects of use of the combined preparation logimax in patients with essential hypertension].
    Ol'binskaia LI; Khapaev BA; Zheleznykh EA
    Ter Arkh; 2002; 74(1):61-3. PubMed ID: 11878064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.